Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Defining the Diversity and Specificity of Neoantigen-Specific T Cells in Chronic Lymphocytic Leukemia

Zhuting Hu, PhD, Jing Sun, PhD, Jintaek Kim, PhD, Annabelle Jacinta Anandappa, BS, Donna Leet, BA, Louise Williams, PhD, David J Bozym, PhD, Christina Chen, BS, Wandi Zhang, MD, Diana Tabbaa, BS, Pavan Bachireddy, MD, Sachet Shukla, PhD, Scott Steelman, PhD, Derin Keskin, PhD, Catherine J. Wu, MD

Blood (2017) 130 (Supplement 1): 386.

https://doi.org/10.1182/blood.V130.Suppl_1.386.386

Published: 2017

Journal Articles

Ibrutinib Can Modulate the T Cell Response in Chronic Lymphocytic Leukemia By Reducing PD1/PDL1 Interactions

Kayo Kondo, PhD, Jan A. Burger, MD PhD, Keating Micheal, MD, Jamie Tran, Muharrem Muftuoglu, May Daher, Hila Shaim, MD, Philip Thompson, MBBS, Nobuhiko Imahashi, MD PhD, Abdullah Alsuliman, William Wierda, MD PhD, Enli Liu, MD MS, Elizabeth J. Shpall, MD, Katayoun Rezvani, MDPhD

Blood (2015) 126 (23): 1737.

https://doi.org/10.1182/blood.V126.23.1737.1737

Published: 2015

Journal Articles

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Thai Hoa Tran, Rochelle Yanofsky, MD, FRCP(C), Donna Johnston, MD, FRCPC, David Dix, MD, Biljana Gillmeister, Marie-Chantal Ethier, BSc, Carol Portwine, Victoria E. Price, MBChB, MD, David Mitchell, Sonia Cellot, MD, Victor A. Lewis, MD, Shayna Zelcer, MD, Mariana Silva, MD, Bruno Michon, MD, FRCPC, Lynette Bowes, MD, Kent Stobart, MD, MSC, Josee Brossard, MD, Joseph Beyene, PhD, Lillian Sung, MD, PhD

Blood (2013) 122 (21): 1415.

https://doi.org/10.1182/blood.V122.21.1415.1415

Published: 2013

Journal Articles

Large Scale Screening for DNA Damage-Induced Transcription Factors as Potential Targets for Treatment of CLL with p53 Apoptotic Defect.

Victoria Weston, PhD, Paul Moss, MBBS, PhD, FRCP, A. Malcolm R Taylor, PhD, Tatjana Stankovic, MD., PhD

Blood (2009) 114 (22): 3439.

https://doi.org/10.1182/blood.V114.22.3439.3439

Published: 2009

Journal Articles

Standardization of Functional Immune Cell-Based Assays: An Integral Aspect to Vaccine and Biologic Development and Validation.

Julie Wilkinson, Cecilia Smith, Sybil D’Costa, PhD, Enrique Rabellino, MD

Blood (2005) 106 (11): 3933.

https://doi.org/10.1182/blood.V106.11.3933.3933

Published: 2005

Journal Articles

Management of Febrile Neutropenia: Single Agent or Combination Therapy?.

Joana Caldas, MD, Teresa Fernandes, MD, Alexandra Monteiro, MD, Luisa Carande, MD, Madalena Silva, MD, Ernesto Cruz, MD, Aida B. Sousa, MD

Blood (2004) 104 (11): 5063.

https://doi.org/10.1182/blood.V104.11.5063.5063

Published: 2004

NARROW

Defining the Diversity and Specificity of Neoantigen-Specific T Cells in Chronic Lymphocytic Leukemia

Ibrutinib Can Modulate the T Cell Response in Chronic Lymphocytic Leukemia By Reducing PD1/PDL1 Interactions

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Large Scale Screening for DNA Damage-Induced Transcription Factors as Potential Targets for Treatment of CLL with p53 Apoptotic Defect.

Standardization of Functional Immune Cell-Based Assays: An Integral Aspect to Vaccine and Biologic Development and Validation.

Management of Febrile Neutropenia: Single Agent or Combination Therapy?.

Email alerts

ASH Publications

American Society of Hematology

Defining the Diversity and Specificity of Neoantigen-Specific T Cells in Chronic Lymphocytic Leukemia

Ibrutinib Can Modulate the T Cell Response in Chronic Lymphocytic Leukemia By Reducing PD1/PDL1 Interactions

Second Bacteremia During Antibiotic Treatment In Children With Acute Myeloid Leukemia: A Report From The Canadian Infections In AML Research Group

Large Scale Screening for DNA Damage-Induced Transcription Factors as Potential Targets for Treatment of CLL with p53 Apoptotic Defect.

Standardization of Functional Immune Cell-Based Assays: An Integral Aspect to Vaccine and Biologic Development and Validation.

Management of Febrile Neutropenia: Single Agent or Combination Therapy?.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only